Mike Zablocki
General Manager
Mike is General Manager of the Malaghan Institute, responsible for the corporate, commercial and support functions of the organisation. He is also a Director of Wellington Zhaotai Therapies Limited, a joint venture established by the Malaghan Institute to develop innovative cell therapies for the global market.
Mike completed a Bachelor of Arts at the University of Bristol, before moving to New Zealand in 2002 when he joined the Malaghan as a database administrator. In 2011 he completed his Postgraduate Diploma in Business Administration at Victoria University of Wellington. He was appointed as General Manager in 2016.
From clinical trial to clinical tool: Bringing CAR-T to patients
26 March 2026
New Zealand has a chance to lead in next-generation cancer treatments
11 March 2026
Award celebrates international collaboration that sparked landmark cancer discovery
10 March 2026
CAR T-cell therapy: 5-part video series
25 February 2026
Momentum is everything: advancing CAR T-cell research for future trials and treatments
25 February 2026
A ground-breaking cancer treatment is within reach – but only if New Zealand acts now
12 February 2026
From clinical trial to clinical tool: Bringing CAR-T to patients
26 March 2026
New Zealand has a chance to lead in next-generation cancer treatments
11 March 2026
Award celebrates international collaboration that sparked landmark cancer discovery
10 March 2026
CAR T-cell therapy: 5-part video series
25 February 2026
Momentum is everything: advancing CAR T-cell research for future trials and treatments
25 February 2026
A ground-breaking cancer treatment is within reach – but only if New Zealand acts now
12 February 2026